Publications found:
36,694
Sort by:
Critical Limb Ischemia - Pipeline Insight, 2021
US$ 2,000.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Critical Limb Ischemia The report also ...
September 2021
60 pages
Hepatitis A - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Hepatitis A - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hepatitis A development. The report provides ...
September 2021
60 pages
Leber hereditary optic neuropathy - Pipeline Insight, 2021
US$ 1,500.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Leber's Hereditary Optic Neuropathy The report also ...
September 2021
60 pages
Cyclin-dependent-kinase-inhibitors - Pipeline Insight, 2021
US$ 2,500.00
... (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details. Pipeline Therapeutics assessment of products for “Cyclin-Dependent Kinase Inhibitor The report ...
September 2021
150 pages
Chronic lymphocytic leukemia - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 5-7 business days DelveInsight’s, “Chronic lymphocytic leukemia – Pipeline Insight, 2021,” report provides comprehensive insights about 60+ compani...
September 2021
120 pages
Central Nervous System Lymphoma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Central Nervous System Lymphoma – Pipeline Insight, 2021,” report provides comprehensive insights about 13+ companies...
September 2021
60 pages
Central Serous Chorioretinopathy - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Central Serous Chorioretinopathy – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and...
September 2021
60 pages
E-Pharmacy Market in India 2021
US$ 950.00
In the recent years, e-pharmacy emerged as a better and more convenient approach that addressed the issues faced by the consumers and provided superior customer solutions over its physical counterpart...
September 2021
76 pages
Spinal Cord Injury - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 72 hours DelveInsight’s, “Spinal Cord Injury - Pipeline Insight, 2021,” report provides comprehensive insights about 35+ companies and 35+ pipeline...
September 2021
80 pages
Advanced Cervical Cancer - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 3-5 business days DelveInsight’s, “Advanced Cervical Cancer - Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies a...
September 2021
60 pages
Advanced Endometrial Cancer - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 3-5 business days DelveInsight’s, “Advanced Endometrial Cancer - Pipeline Insight, 2021,” report provides comprehensive insights about 25+ companie...
September 2021
60 pages
Advanced Gastric Carcinoma - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 3-5 business days DelveInsight’s, “Advanced Gastric Carcinoma - Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies...
September 2021
60 pages
Advanced Renal Cell Carcinoma - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 3-5 business days DelveInsight’s, “Advanced Renal Cell Carcinoma - Pipeline Insight, 2021,” report provides comprehensive insights about 40+ compan...
September 2021
60 pages
Behзet’s syndrome - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Behзet’s syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline dr...
September 2021
60 pages
Congenital Adrenal Hyperplasia - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Congenital Adrenal Hyperplasia – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5...
September 2021
60 pages
Erosive esophagitis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “Erosive esophagitis - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline...
September 2021
60 pages
Generalized Anxiety Disorder - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Generalized Anxiety Disorder – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and...
September 2021
60 pages
Heart failure with preserved ejection fraction (HFpEF)
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Heart failure with preserved ejection fraction (HFpEF) - Pipeline Insight, 2021,” report provides comprehensive insights...
September 2021
60 pages
Heart Failure With Reduced Ejection Fraction (HFrEF)
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Heart Failure With Reduced Ejection Fraction (HFrEF) - Pipeline Insight, 2021,” report provides comprehensive insights ab...
September 2021
60 pages
Kidney Transplant Rejection - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 2-3 business days DelveInsight’s, “Kidney Transplant Rejection – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companie...
September 2021
60 pages
Leber congenital amaurosis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Leber congenital amaurosis - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+...
September 2021
60 pages
Lung transplant rejection - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Lung transplant rejection - Pipeline Insight, 2021,” report provides comprehensive insights about 7+ companies and 7+ pip...
September 2021
60 pages
Meibomian Gland Dysfunction - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Meibomian Gland Dysfunction – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 8...
September 2021
60 pages
Myositis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 3-5 business days DelveInsight’s, “Myositis - Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 15+ pipeline...
September 2021
60 pages
Nephrotic syndrome - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Nephrotic syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline d...
September 2021
60 pages
Niemann-Pick Type C Disease - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Niemann-Pick Type C Disease – Pipeline Insight, 2021,” report provides comprehensive insights about 13+ companies and...
September 2021
60 pages
Peripheral nerve injuries - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Peripheral nerve injuries - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ p...
September 2021
60 pages
Proliferative vitreoretinopathy - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Proliferative vitreoretinopathy - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and...
September 2021
60 pages
Rabies infection - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Rabies infection – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipelin...
September 2021
60 pages
Ragweed pollen hypersensitivity - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Ragweed pollen hypersensitivity - Pipeline Insight, 2021,” report provides comprehensive insights about 2+ companies and...
September 2021
60 pages
Schizoaffective Disorder - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Schizoaffective Disorder – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipe...
September 2021
60 pages
Sturge-Weber Syndrome - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Sturge-Weber Syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipelin...
September 2021
60 pages
Toll-like-receptor-agonists - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 3-4 working days DelveInsight’s, “Toll-like-receptor-agonists - Pipeline Insight, 2021,” report provides comprehensive insights about 35+ companies...
September 2021
100 pages
Ulcerative proctitis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Ulcerative proctitis - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline...
September 2021
60 pages
Estrogen Receptor Beta - Drugs In Development, 2021
US$ 3,500.00
Estrogen Receptor Beta - Drugs In Development, 2021 SUMMARY According to the recently published report 'Estrogen Receptor Beta - Drugs In Development, 2021'; Estrogen Receptor Beta (ER Beta or Nuclear...
August 2021
77 pages
Gamma Secretase (EC 3.4.23.) - Drugs In Development, 2021
US$ 3,500.00
Gamma Secretase (EC 3.4.23.) - Drugs In Development, 2021 SUMMARY According to the recently published report 'Gamma Secretase - Drugs In Development, 2021'; Gamma Secretase (EC 3.4.23.) pipeline Targe...
August 2021
87 pages
Retinoic Acid Receptor Alpha - Drugs In Development, 2021
US$ 3,500.00
Retinoic Acid Receptor Alpha - Drugs In Development, 2021 SUMMARY Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) pipeline Target constitutes...
August 2021
76 pages
Retinoic Acid Receptor Gamma - Drugs In Development, 2021
US$ 3,500.00
Retinoic Acid Receptor Gamma - Drugs In Development, 2021 SUMMARY Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) - Retinoic acid receptor ga...
August 2021
88 pages
